An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma
Clinical trial NCT02726581 · COMPLETED
Trial details
- NCT number
- NCT02726581
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-10
- Primary completion
- 2022-03-09
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.